Position history for RTW INVESTMENTS, LP's holdings in CRINETICS PHARMACEUTICALS IN
RTW INVESTMENTS, LP holds 1.4M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $62.9M as of 2025-Q4. The position was increased (++54.9% shares). CRNX represents 0.6% of RTW INVESTMENTS, LP's portfolio.
Current Value
$62.9M
Current Shares
1.4M
Total Value Change
+$49.5M
Total Shares Change
+884,326
Other major holders of CRNX: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 1.4M |
+54.9% |
| $62.9M |
| 0.6% |
| $47.39 |
59 |
| 2025-Q3 | Increased | 872,387 | +86.8% | $36.3M | 0.4% | $43.51 | 54 |
| 2025-Q2 | New | 467,000 | - | $13.4M | 0.2% | $29.96 | 46 |